Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Multimodal Digital Biomarkers for Evidence-Based Mental Health Decision Support and Monitoring

Ziel

AIREST (Artificial-Intelligence-based Rapid Emotional Screening Test) is an AI-driven Software as a Medical Device (SaMD) in development that uses modern AI and machine-learning methods to analyse multimodal behavioural biomarkers from short voice-and-video interactions. It combines acoustic and linguistic features of speech, vocal prosody, facial-expression dynamics and simple attention-related measures into objective, quantitative indicators of mental health.The system is intended for early detection, standardised screening and diagnostic support for mental health conditions, including depressive episodes and recurrent depressive disorder, generalised anxiety disorder, mixed anxiety and depressive disorder and post-traumatic stress disorder (PTSD). By processing a few minutes of guided interaction, AIREST generates risk scores and trend indicators that can be integrated into existing clinical workflows and electronic health records.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-EIC - HORIZON EIC Grants

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-EIC-2025-UKRAINIANTECH-01

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

LIMITED LIABILITY COMPANY AIREST
Netto-EU-Beitrag
€ 494 964,38
Adresse
HRYSHKA MYKHAILA ST 4 OFFICE 10/1
02072 KYIV
Ukraine
KMU
Ja
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
Keine Daten